Status:

COMPLETED

Gamma tACS in Alzheimer's Disease

Lead Sponsor:

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Conditions:

Alzheimer Disease

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Brain oscillations are ubiquitous in the human brain and have been implicated in cognitive and behavioral states defined in precisely tuned neural networks. In neurodegenerative disorders, neurodegene...

Detailed Description

Brain oscillations are ubiquitous in the human brain and have been implicated in cognitive and behavioral states defined in precisely tuned neural networks. In neurodegenerative disorders, neurodegene...

Eligibility Criteria

Inclusion

  • \- Mild Cognitive Impairment due to Alzheimer's disease (according to Albert et al., Alzheimers Dement 2011).

Exclusion

  • Cerebrovascular disorders, previous stroke, hydrocephalus, and intra-cranial mass documented by MRI.
  • History of traumatic brain injury or other neurological diseases.
  • Serious medical illness other than FTD
  • History of seizures
  • Pregnancy
  • Metal implants in the head (except dental fillings)
  • Electronic implants (i.e. pace-maker, implanted medical pump)
  • Age \<18 years

Key Trial Info

Start Date :

August 20 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 30 2020

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT04515433

Start Date

August 20 2020

End Date

September 30 2020

Last Update

March 19 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

AO Spedali Civili

Brescia, BS, Italy, 25100